ABCG2 and cancer: A previous study on the use of the AG-221-DAU combination suggested that AG-221 synergizes with daunorubicin by inhibiting AKR1C3 enzyme and preventing ABC transporters’ activities, thereby sensitizing cancer cells against drug molecules29.